1.
O.F.I.L
; 32(3): 223-224, julio 2022.
Article
in Spanish
| IBECS
| ID: ibc-208773
2.
An. pediatr. (2003, Ed. impr.)
; 80(3): e102-e103, mar. 2014.
Article
in Spanish
| IBECS
| ID: ibc-119894
ABSTRACT
No disponible
Subject(s)
Humans , Male , Female , Child, Preschool , Homeopathic Remedy , Plant Extracts/adverse effects , Dietary Supplements/adverse effects , Phytotherapy/adverse effects
3.
An Pediatr (Barc)
; 80(3): e102-3, 2014 Mar.
Article
in Spanish
| MEDLINE
| ID: mdl-24269548
4.
Pediatr. aten. prim
; 11(supl.15): 81-100, abr.-jun. 2009. tab, ilus
Article
in Spanish
| IBECS
| ID: ibc-75233
ABSTRACT
En este artículo se expone el marco normativo que se aplica a los cosméticos, según lanormativa española en el marco europeo de armonización. En particular se exponen los criteriosde utilización de los excipientes de estos productos manufacturados, en concreto delos colorantes y conservantes. Estos pueden ser factores de riesgo de las reagudizaciones dedermatitis atópica (DA), debido a su poder alergizante. La vigilancia de los efectos adversosde los cosméticos (cosmetovigilancia) debe ser una actividad con mayor implantación
En este artículo se expone el marco normativo que se aplica a los cosméticos, según lanormativa española en el marco europeo de armonización. En particular se exponen los criteriosde utilización de los excipientes de estos productos manufacturados, en concreto delos colorantes y conservantes. Estos pueden ser factores de riesgo de las reagudizaciones dedermatitis atópica (DA), debido a su poder alergizante. La vigilancia de los efectos adversosde los cosméticos (cosmetovigilancia) debe ser una actividad con mayor implantación(AU)
Subject(s)
Humans , Male , Female , Evidence-Based Medicine , Dermatitis, Atopic/diagnosis , Dermatitis, Atopic/epidemiology , Dermatitis, Atopic/therapy , Steroids/therapeutic use , Emollients/therapeutic use , Breast Feeding/epidemiology , Probiotics/therapeutic use , Primary Prevention/methods , Self Care , Primary Prevention/organization & administration , Primary Prevention/standards , Primary Prevention/trends , Adrenal Cortex Hormones/therapeutic use , Calcineurin/therapeutic use
5.
Pediatr. aten. prim
; 7(supl.4): s75-s91, oct. 2005. tab, ilus
Article
in Spanish
| IBECS
| ID: ibc-132676
Subject(s)
Humans , Male , Female , Child , Pharmacovigilance , Vaccines/immunology , Mass Vaccination/methods , Mass Vaccination/trends , Immunization Programs/organization & administration , Immunization Programs/standards , Poliomyelitis/immunology , Drug Monitoring/methods , Drug Monitoring/standards , Drug Monitoring/trends
6.
[Drug safety. Notes about surveillance]. / Seguridad de medicamentos. Notas sobre farmacovigilancia.
Farm Hosp
; 28(3): 225-8, 2004.
Article
in Spanish
| MEDLINE
| ID: mdl-15222877
7.
Farm. hosp
; 28(3): 225-228, mayo-jun. 2004.
Article
in Es
| IBECS
| ID: ibc-34101
ABSTRACT
No disponible
Subject(s)
Humans , Product Surveillance, Postmarketing , Product Surveillance, Postmarketing , Pharmaceutical Preparations , Safety
8.
[Drug safety. Notes about surveillance]. / Seguridad de Medicamentos. Notas sobre farmacovigilancia.
Farm Hosp
; 28(1): 68-71, 2004.
Article
in Spanish
| MEDLINE
| ID: mdl-15012183
Subject(s)
Anti-HIV Agents/therapeutic use , Bone Marrow Diseases/chemically induced , Chemical and Drug Induced Liver Injury/etiology , Fires , Isoxazoles/adverse effects , Methyl Ethers/chemistry , Anesthetics, Inhalation/chemistry , Antiretroviral Therapy, Highly Active , Antirheumatic Agents/adverse effects , Chemical and Drug Induced Liver Injury/mortality , HIV Infections/drug therapy , Humans , Leflunomide , Sevoflurane
9.
Farm Hosp
; 27(5): 331-5, 2003.
Article
in Spanish
| MEDLINE
| ID: mdl-14576924
Subject(s)
Fructose/analogs & derivatives , Product Surveillance, Postmarketing , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Anticonvulsants/adverse effects , Antiviral Agents/therapeutic use , Aspirin/adverse effects , Carbamates/adverse effects , Drug Interactions , Drug Therapy, Combination , Fever/chemically induced , Fructose/adverse effects , Gemfibrozil/adverse effects , Hypoglycemia/chemically induced , Hypoglycemic Agents/adverse effects , Hypohidrosis/chemically induced , Hypolipidemic Agents/adverse effects , Piperidines/adverse effects , Reye Syndrome/chemically induced , Topiramate , Treatment Failure
10.
Farm Hosp
; 27(3): 199-200, 2003.
Article
in Spanish
| MEDLINE
| ID: mdl-12835823
11.
Farm Hosp
; 27(3): 201-2, 2003.
Article
in Spanish
| MEDLINE
| ID: mdl-12835825
12.
Farm Hosp
; 27(3): 200-1, 2003.
Article
in Spanish
| MEDLINE
| ID: mdl-12835824
13.
[Drug safety. Notes about surveillance]. / Seguridad de medicamentos. Notas sobre farmacovigilancia.
Farm Hosp
; 27(1): 60-3, 2003.
Article
in Spanish
| MEDLINE
| ID: mdl-12607020
Subject(s)
Drug-Related Side Effects and Adverse Reactions , Hirudins/analogs & derivatives , Product Surveillance, Postmarketing , Anaphylaxis/chemically induced , Antibodies, Monoclonal/adverse effects , Antibodies, Monoclonal, Humanized , Antidepressive Agents, Second-Generation/adverse effects , Antiviral Agents/adverse effects , Chemical and Drug Induced Liver Injury/pathology , Hirudins/adverse effects , Humans , Palivizumab , Piperazines , Recombinant Proteins/adverse effects , Triazoles/adverse effects
14.
Farm. hosp
; 26(3): 195-198, mayo 2002.
Article
in Es
| IBECS
| ID: ibc-15344
ABSTRACT
No disponible
Subject(s)
Humans , Product Surveillance, Postmarketing , Botulinum Toxins/therapeutic use , Anti-Dyskinesia Agents/therapeutic use , Epoetin Alfa/therapeutic use
15.
16.
17.
18.
Farm. hosp
; 25(5): 319-321, sept. 2001.
Article
in Es
| IBECS
| ID: ibc-8378
ABSTRACT
No disponible
